Targeting apoptotic and autophagic pathways for cancer therapeutics

Cancer Letters

Volumn 300, Issue 2, 2011, Pages 105-114

  Liu, Jun jie ^a   Lin, Mou ^a   Yu, Jia ying ^a   Liu, Bo ^a   Bao, Jin ku ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; Cancer; Pathways

Indexed keywords

6 CHLORO 8 NICOTINAMIDO BETA CARBOLINE; ADVEXIN; ARSENIC TRIOXIDE; BECLIN 1; BORTEZOMIB; CASPASE; CASPASE INHIBITOR; GROWTH FACTOR RECEPTOR; HLA DR4 ANTIGEN; HLA DR5 ANTIGEN; IMATINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; ORIDONIN; PROTEIN KINASE B INHIBITOR; PROTEIN P53; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOPHAGY; CANCER CELL DESTRUCTION; CANCER RESEARCH; CANCER STAGING; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE REGULATION; CLINICAL TRIAL; DOUBLE STRANDED DNA BREAK; DRUG EFFICACY; DRUG TARGETING; GENE ACTIVATION; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; METABOLIC STRESS; MITOSIS INHIBITION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SHORT SURVEY; SIGNAL TRANSDUCTION; TARGET CELL DESTRUCTION;

HARNESS;

EID: 78649634631     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.10.001     Document Type: Review

References (107)

1. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
2. Beth L. Autophagy and cancer. Nature 2007, 446:745-747.
3. Michael O.H. The biochemistry of apoptosis. Nature 2000, 407:770-777.
4. Levine B., Klionsky D.J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 2004, 6:463-477.
5. Hannigan A.M., Gorski S.M. Macroautophagy: the key ingredient to a healthy diet?. Autophagy 2009, 5:140-151.
6. Andrew T. Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis 2008, 13:1-9.
7. Cheng Y., Qiu F., Ye Y.C., Guo Z.M., Tashiro S., Onodera S., Ikejima T. Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells. FEBS J. 2009, 276:1291-1306.
8. Liu B., Cheng Y., Zhang B., Bian H.J., Bao J.K. Polygonatum cyrtonema lectin induces apoptosis and autophagy in human melanoma A375 cells through a mitochondria-mediated ROS-p38-p53 pathway. Cancer Lett. 2009, 275:54-60.
9. Cheng Y., Qiu F., Ikejima T. Molecular mechanisms of oridonin-induced apoptosis and autophagy in murine fibrosarcoma L929 cells. Autophagy 2009, 5:430-443.
10. Scott W.L., Athena W.L. Apoptosis in cancer. Carcinogenesis 2000, 21:485-495.
11. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Brit. J. Cancer 1972, 26:239-257.
12. Zapata J.M., Pawlowski K., Haas E., Ware C.F., Godzik A., Reed J.C. A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains. J. Biol. Chem. 2001, 276:24242-24252.
13. Lavrik I., Golks A., Krammer P.H. Death receptor signaling. J. Cell Sci. 2005, 118:265-267.
14. Hockenbery D., Nunez G., Milliman C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990, 348:334-336.
15. Reed J.C. Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Semin. Hematol. 1997, 34:9-19.
16. Creagh E.M., Martin S.J. Caspases: cellular demolition experts. Biochem. Soc. Trans. 2001, 2:696-701.
17. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991, 51:6304-6311.
18. Vermeulen K., Berneman Z.N., Van Bockstaele D.R. Cell cycle and apoptosis. Cell Proliferat. 2003, 36:165-175.
19. Benchimol S. P53-dependent pathways of apoptosis. Cell Death Differ. 2001, 8:1049-1051.
20. Yu J., Wang Z., Kinzler K.W., Vogelstein B., Zhang L. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100:1931-1936.
21. Adams J.M., Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007, 26:1324-1337.
22. Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 2007, 87:99-163.
23. Zheng Y., Shi Y., Tian C., Jiang C., Jin H., Chen J., Almasan A., Tang H., Chen Q. Essential role of the voltage-dependent anion channel (VDAC) in mitochondrial permeability transition pore opening and cytochrome c release induced by arsenic trioxide. Oncogene 2004, 23:1239-1247.
24. Lacronique V., Mignon A., Fabre M., Viollet B., Rouquet N., Molina T., Porteu A., Henrion A., Bouscary D., Varlet P., Joulin V., Kahn A. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat. Med. 1996, 2:80-86.
25. Merino D., Bouillet P. The Bcl-2 family in autoimmune and degenerative disorders. Apoptosis 2009, 14:570-583.
26. Sharpe J.C., Arnoult D., Youle R.J. Control of mitochondrial permeability by Bcl-2 family members. Biochim. Biophys. Acta - Mol. Cell Res. 2004, 1644:107-113.
27. Pan G.H., ORourke K., Dixit V.M. Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J. Biol. Chem. 1998, 273:5841-5845.
28. Schaeffer H.J., Weber M.J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 1999, 19:2435-2444.
29. Deng X., Ruvolo P., Carr B., May W.S. Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases. Proc. Natl. Acad. Sci. USA 2000, 97:1578-1583.
30. Chu C.T., Levinthal D.J., Kulich S.M., Chalovich E.M., DeFranco D.B. Oxidative neuronal injury. The dark side of ERK1/2. Eur. J. Biochem. 2004, 271:2060-2066.
31. Pavlovic D., Andersen N.A., Mandrup-Poulsen T., Eizirik D.L. Activation of extracellular signal-regulated kinase (ERK)1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic beta-cells. Eur. Cytokine Netw. 2000, 11:267-274.
32. Persons D.L., Yazlovitskaya E.M., Pelling J.C. Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. J. Biol. Chem. 2000, 275:35778-35785.
33. Petrache I., Choi M.E., Otterbein L.E., Chin B.Y., Mantell L.L., Horowitz S., Choi A.M.K. Mitogen-activated protein kinase pathway mediates hyperoxia-induced apoptosis in cultured macrophage cells. Am. J. Physiol. 1999, 277:589-595.
34. Yu C., Wang S., Dent P., Grant S. Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogen-activated protein kinase pathway. Mol. Pharmacol. 2001, 60:143-154.
35. Huang G., Ma W.Y., Maxine A., Sun Y., Dong Z. P38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389. J. Biol. Chem. 1999, 274:12229-12235.
36. Keller D., Zeng X., Li X., Kapoor M., Iordanov M.S., Taya Y., Lozano G., Magun B., Lu H. The p38 MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53. Biochem. Biophys. Res. Commun. 1999, 261:464-471.
37. Dhillon A.S., Hagan S., Rath O., Kolch W. MAP kinase signaling pathway in cancer. Oncogene 2007, 26:3279-3290.
38. Maldonado V., Melendez-Zajgla J., Ortega A. Modulation of NF-kappaB, and Bcl-2 in apoptosis induced by cisplatin in HeLa cells. Mutat. Res. 1997, 381:67-75.
39. Ghobrial I.M., Witzig T.E., Adjei A.A. Targeting apoptosis pathways in cancer therapy. CA Cancer J. Clin. 2005, 55:178-194.
40. Karin M., Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 2005, 5:749-759.
41. Petiot A., Ogier-Denis E., Blommaart E.F., Meijer A.J., Codogno P. Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J. Biol. Chem. 2000, 275:992-998.
42. Dolcet X., Llobet D., Pallares J., Matias-Guiu X. NF-κB in development and progression of human cancer. Virchows Arch. 2005, 446:475-482.
43. Yamamoto Y., Gaynor R.B. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 2001, 107:135-142.
44. Hinata K., Gervin A.M., Jennifer Zhang Y., Khavari P.A. Divergent gene regulation and growth effects by NF-kappa B in epithelial and mesenchymal cells of human skin. Oncogene 2003, 22:1955-1964.
45. Bash J., Zong W.X., Gelinas C. C-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition. Mol. Cell Biol. 1997, 17:6526-6536.
46. Liang X.H., Jackson S., Seaman M., Brown K., Kempkes B., Hibshoosh H., Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999, 402:672-676.
47. Stromhaug P.E., Klionsky D.J. Approaching the molecular mechanism of autophagy. Traffic 2001, 2:524-531.
48. Kundu M., Thompson C.B. Autophagy: basic principles and relevance to disease. Annu. Rev. Pathol. 2008, 3:427-455.
49. Maiuri M.C., Tasdemir E., Criollo A., Morselli E., Vicencio J.M., Carnuccio R., Kroemer G. Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ. 2009, 16:87-93.
50. Nicholson K.M., Anderson N.G. The protein kinase B/Akt signaling pathway in human malignancy. Cell Signal. 2002, 14:381-395.
51. Majumder P.K., Sellers W.R. Akt-regulated pathways in prostate cancer. Oncogene 2005, 24:7465-7474.
52. Gonzalez-Polo R.A., Boya P., Pauleau A.L., Jalil A., Larochette N., Souquere S., Eskelinen E.L., Pierron G., Saftig P., Kroemer G. The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J. Cell Sci. 2005, 118:3091-3102.
53. Osaki1 M., Oshimura M., Ito H. PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 2004, 9:667-676.
54. Chen N., Karantza-Wadsworth V. Role and regulation of autophagy in cancer. Biochim. Biophys. Acta - Mol. Cell Res. 2009, 1793:1516-1523.
55. LoPiccolo J., Blumenthal G., Bernstein W., Dennis P. Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. Drug Resist. Updates 2007, 11:32-50.
56. Yap T.A., Garrett M.D., Walton M.I., Raynaud F., de Bono J.S., Workman P. Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises. Curr. Opin. Pharmacol. 2008, 8:393-412.
57. Panigrahi A.R., Pinder S.E., Chan S.Y., Paish E.C., Robertson J.F.R., Ellis I.O. The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome. J. Pathol. 2004, 204:93-100.
58. Qu X., Yu J., Bhagat G., Furuya N., Hibshoosh H., Troxel A., Rosen J., Eskelinen E.L., Mizushima N., Ohsumi Y., Cattoretti G., Levine B. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 2003, 112:1809-1820.
59. Aita V.M., Liang X.H., Murty V.V., Pincus D.L., Yu W., Cayanis E., Kalachikov S., Gilliam T.C., Levine B. Cloning and genomic organization of Beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999, 59:59-65.
60. Liang C., Feng P., Ku B., Dotan I., Canaani D., Oh B.H., Jung J.U. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat. Cell Biol. 2006, 8:688-699.
61. Itakura E., Kishi C., Inoue K., Mizushima N. Beclin1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol. Biol. Cell 2008, 19:5360-5372.
62. Takahashi Y., Coppola D., Matsushita N., Cualing H.D., Sun M., Sato Y., Liang C., Jung J.U., Cheng J.Q., Mul J.J., Pledger W.J., Wang H.G. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat. Cell Biol. 2007, 9:1142-1151.
63. Baehrecke E.H. Autophagy: dual roles in life and death?. Nat. Rev. Mol. Cell Biol. 2005, 6:505-510.
64. Xie Z., Klionsky D.J. Autophagosome formation: core machinery and adaptations. Nat. Cell Biol. 2007, 9:1102-1109.
65. Yorimitsu T., Klionsky D.J. Autophagy: molecular machinery for self-eating. Cell Death Differ. 2005, 12:1542-1552.
66. Ohsumi Y., Mizushima N. Two ubiquitin-like conjugation systems essential for autophagy. Semin. Cell Dev. Biol. 2004, 15:231-236.
67. Pattingre S., Bauvy C., Codogno P. Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells. J. Biol. Chem. 2003, 278:16667-16674.
68. Karnoub A.E., Weinberg R.A. Ras oncogenes: split personalities. Nat. Rev. Mol. Cell Biol. 2008, 9:517-531.
69. He C., Klionsky D.J. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 2009, 43:67-93.
70. Shintani T., Klionsky D.J. Autophagy in health and disease: a double-edged sword. Science 2004, 306:990-995.
71. Mathew R., Wadsworth V.K., White E. Role of autophagy in cancer. Nat. Rev. Cancer 2007, 7:961-967.
72. Degenhardt K., Mathew R., Beaudoin B., Bray K., Anderson D., Chen G., Mukherjee C., Shi Y., Gelinas C., Fan Y., Nelson D.A., Jin S., White E. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006, 10:51-64.
73. Karantza-Wadsworth V., Patel S., Kravchuk O., Chen G.H., Mathew R., Jin S.K., White E. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev. 2007, 21:1621-1635.
74. Kroemer G., Jaattela M. Lysosomes and autophagy in cell death control. Nat. Rev. Cancer 2005, 5:886-897.
75. Kondo Y., Kanzawa T., Sawaya R., Kondo S. The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer 2005, 5:726-734.
76. Djavaheri-Mergny M., Botti J., Codogno P. Autophagy and autophagic cell death. Apoptosis, Senescence, and Cancer 2007, 93-107. Humana Press, N.J. D.A. Gewirtz, S.E. Holt, S. Grant (Eds.).
77. Gozuacik D., Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004, 23:2891-2906.
78. Amaravadi R.K., Thompson C.B. The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin. Cancer Res. 2007, 13:7271-7279.
79. Edinger A., Thompson C. Defective autophagy leads to cancer. Cancer Cell 2009, 4:422-424.
80. Chen N., Debnath J. Autophagy and tumorigenesis. FEBS Lett. 2010, 584:1427-1435.
81. Young A.R.J., Narita M., Ferreira M., Kirschner K., Sadaie M., Darot J.F.J., Tavare1 S., Arakawa S., Shimizu S., Watt F.M., Narita M. Autophagy mediates the mitotic senescence transition. Genes Dev. 2009, 23:798-803.
82. Toth S., Nagy K., Palfia Z., Rez G. Cellular autophagic capacity changes during azaserine-induced tumour progression in the rat pancreas. Up-regulation in all premalignant stages and down-regulation with loss of cycloheximide sensitivity of segregation along with malignant transformation. Cell Tissue Res. 2002, 309:409-416.
83. Maiuri M.C., Zalckvar E., Kimchi A., Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 2007, 8:741-752.
84. Liu B., Bian H.J., Bao J.K. Plant lectins: potential antineoplastic drugs from bench to clinic. Cancer Lett. 2010, 287:1-12.
85. Tasdemir E., Maiuri M.C., Galluzzi L., Vitale I., Mergny M.D., DAmelio M. Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol. 2008, 10:676-687.
86. Levine B., Abrams J. P53: the Janus of autophagy?. Nat. Cell Biol. 2008, 10:637-639.
87. Morselli E., Galluzzi L., Kepp O., Vicencio J.M., Criollo A., Maiuri M.C., Kroemer G. Anti- and pro-tumor functions of autophagy. Biochim. Biophys. Acta - Mol. Cell Res. 2009, 1793:1524-1532.
88. Moretti L., Cha Y.I., Niermann K.J., Lu B. Switch between apoptosis and autophagy: radiation-induced endoplasmic reticulum stress?. Cell Cycle 2007, 6:793-798.
89. Levine B., Sinha S., Kroemer G. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 2008, 4:600-606.
90. Maiuri M.C., Criollo A., Kroemer G. Crosstalk between apoptosis and autophagy within the Beclin 1 interactome. EMBO J. 2010, 29:515-516.
91. Oltersdorf T., Elmore S.W., Shoemaker A.R., Armstrong R.C., Auger D.J., Belli B.A. An inhibitor of Bcl-2 family proteins induces regression of solid tumors. Nature 2005, 435:677-681.
92. Maiuri M.C., Toumelin G.L., Criollo A., Rain J.C., Gautier F., Juin P. Functional and physical interaction between Bcl-XL and a BH3-like domain in Beclin-1. EMBO J. 2007, 26:2527-2539.
93. Yu L., Alva A., Su H., Dutt P., Freundt E., Welsh S., Baehrecke E.H., Lenardo M.J. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004, 304:1500-1502.
94. Djavaheri-Mergny M., Maiuri M.C., Kroemer G. Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1. Oncogene 2010, 29:1717-1719.
95. Wirawan E., Walle L.V., Kersse K., Cornelis S., Claerhout S., Vanoverberghe I., Roelandt R., Rycke R.D., Verspurten J., Declercq W., Agostinis P., Berghe T.V., Lippens S., Vandenabeele P. Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis. 2010, 1:1-10.
96. Faivre S., Kroemer G., Raymond E. Current development of mTOR inhibitors as anticancer agents. Nat. Rev. Drug Discov. 2006, 5:671-688.
97. Dalby K.N., Tekedereli I., Lopez-Berestein G., Ozpolat B. Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy 2010, 6:322-329.
98. Liu B., Cheng Y., Liu Q., Bao J.K., Yang J.M. Autophagic pathways as new targets for cancer drug development. Acta Pharmacol. Sinica 2010, 31:1154-1164.
99. Kim M., Rao M.V., Tweardy D.J., Prakash M., Galili U., Gorelik E. Lectin-induced apoptosis of tumour cells. Glycobiology 1993, 3:447-453.
100. Nauta A.J., Raaschou-Jensen N., Roos A., Daha M.R., Madsen H.O., Borrias-Essers M.C., Ryder L.P., Koch C., Garred P. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur. J. Immunol. 2003, 33:2853-2863.
101. Liu B., Li C.Y., Bian H.J., Min M.W., F Chen L., Bao J.K. Antiproliferative activity and apoptosis-inducing mechanism of Concanavalin A on human melanoma A375 cells. Arch. Biochem. Biophys. 2009, 482:1-6.
102. Li D., Cui Q., Chen S.G., Wu L.J., Tashiro S., Onodera S., Ikejima T. Inactivation of ras and changes of mitochondrial membrane potential contribute to oridonin-induced autophagy in a431 cells. J. Pharmacol. Sci. 2007, 105:22-33.
103. Stauder H., Kreuser E.D. Mistletoe extracts standardised in terms of mistletoe lectins (ML I) in oncology: current state of clinical research. Onkologie 2002, 25:374-380.
104. B. Liu, J.M. Wu, J. Li, J.J. Liu, W.W. Li, C.Y. Li, H.L. Xu, J.K. Bao, Polygonatum cyrtonema lectin induces murine fibrosarcoma L929 cell apoptosis and autophagy via blocking Ras-Raf and PI3K-Akt signaling pathways, Biochimie, doi:. doi:10.1016/j.biochi.2010.08.009.
105. Chang C.P., Yang M.C., Liu H.S., Lin Y.S., Lei H.Y. Concanavalin A induces autophagy in hepatoma cells and has a therapeutic effect in a murine in situ hepatoma model. Hepatology 2007, 45:286-296.
106. Cheng Y., Qiu F., Huang J., Tashiro S., Onodera S., Ikejima T. Apoptosis-suppressing and autophagy-promoting effects of calpain on oridonin-induced A375 cell death. Arch. Biochem. Biophys. 2008, 475:148-155.
107. Cheng Y., Qiu F., Ye Y.C., Tashiro S., Onodera S., Ikejima T. Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells. Arch. Biochem. Biophys. 2009, 490:70-75.